Cargando…
Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
Current therapies for advanced hepatocellular carcinoma (HCC) are marginally effective and exacerbate underlying liver disease. The ability of immunotherapy to elicit nontoxic, systemic, long-lived anti-tumor activity makes it particularly well-suited for use in the setting of HCC. While therapeutic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376967/ https://www.ncbi.nlm.nih.gov/pubmed/22720211 http://dx.doi.org/10.4161/onci.1.1.18344 |